tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

UNCY Stock Latest News

Buy Rating for Unicycive Therapeutics Amid Favorable Risk/Reward and Strategic Growth Opportunities
RatingsBuy Rating for Unicycive Therapeutics Amid Favorable Risk/Reward and Strategic Growth Opportunities
2d ago
UNCY
Promising Prospects for Unicycive Therapeutics: Buy Rating Backed by Upcoming Milestones and Strategic Preparations
PremiumRatings
Promising Prospects for Unicycive Therapeutics: Buy Rating Backed by Upcoming Milestones and Strategic Preparations
2d ago
UNCY
Unicycive Therapeutics price target raised to $7.50 from $4 at H.C. Wainwright
PremiumThe Fly
Unicycive Therapeutics price target raised to $7.50 from $4 at H.C. Wainwright
2d ago
UNCY
Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)
PremiumThe Fly
Unicycive Therapeutics reports FY24 EPS (56c), consensus (51c)
3d ago
UNCY
Is UNCY a Buy, Before Earnings?
PremiumPre-Earnings
Is UNCY a Buy, Before Earnings?
10d ago
UNCY
Unicycive to present patient reported outcomes data from UNI-OLC-201 study
PremiumThe FlyUnicycive to present patient reported outcomes data from UNI-OLC-201 study
21d ago
UNCY
Unicycive Therapeutics’ OLC shows synergy with tenapanor in published study
Premium
The Fly
Unicycive Therapeutics’ OLC shows synergy with tenapanor in published study
1M ago
UNCY
Unicycive announces publication of patient perspectives on phosphate management
Premium
The Fly
Unicycive announces publication of patient perspectives on phosphate management
2M ago
UNCY
Unicycive Therapeutics announces publication of OLC dose escalation data
PremiumThe Fly
Unicycive Therapeutics announces publication of OLC dose escalation data
3M ago
UNCY
Unicycive announces puvlication of OLC positive bioequivalence data
PremiumThe Fly
Unicycive announces puvlication of OLC positive bioequivalence data
4M ago
UNCY
Unicycive Therapeutics price target raised to $4 from $2.50 at H.C. Wainwright
PremiumThe Fly
Unicycive Therapeutics price target raised to $4 from $2.50 at H.C. Wainwright
5M ago
UNCY
Unicycive Therapeutics files $100M mixed securities shelf
PremiumThe Fly
Unicycive Therapeutics files $100M mixed securities shelf
5M ago
UNCY
Unicycive Therapeutics reports Q3 EPS (13c), consensus (15c)
PremiumThe FlyUnicycive Therapeutics reports Q3 EPS (13c), consensus (15c)
5M ago
UNCY
Unicycive Therapeutics expects cash to fund operations into 2026
Premium
The Fly
Unicycive Therapeutics expects cash to fund operations into 2026
5M ago
UNCY
Unicycive Therapeutics announces U.S. FDA acceptane for NDA for OLC
Premium
The Fly
Unicycive Therapeutics announces U.S. FDA acceptane for NDA for OLC
5M ago
UNCY
UNCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
UNCY Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
UNCY
Unicycive presents on development progress of oxylanthanum carbonate
PremiumThe Fly
Unicycive presents on development progress of oxylanthanum carbonate
5M ago
UNCY
Unicycive Therapeutics completes UNI-494 Phase 1 study
PremiumThe Fly
Unicycive Therapeutics completes UNI-494 Phase 1 study
6M ago
UNCY
Unicycive Therapeutics submits NDA to FDA for oxylanthanum carbonate
PremiumThe Fly
Unicycive Therapeutics submits NDA to FDA for oxylanthanum carbonate
7M ago
UNCY
Unicycive price target lowered to $2.50 from $4.50 at H.C. Wainwright
PremiumThe FlyUnicycive price target lowered to $2.50 from $4.50 at H.C. Wainwright
8M ago
UNCY
Unicycive Therapeutics reports Q2 EPS (15c), consensus (19c)
Premium
The Fly
Unicycive Therapeutics reports Q2 EPS (15c), consensus (19c)
8M ago
UNCY
Is UNCY a Buy, Before Earnings?
Premium
Pre-Earnings
Is UNCY a Buy, Before Earnings?
8M ago
UNCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >